Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sun Rose International is a pharmaceutical company based in Mumbai, India, that specializes in the export and supply of Active Pharmaceutical Ingredients (APIs), pharmaceutical pellets, and finished dosage forms. Established in 2004, the company serves as a global provider of high-quality generic medications across various therapeutic areas, including cardiology, gastroenterology, and oncology. They offer a diverse portfolio that includes synthetic drugs, peptides, and herbal extracts, catering to the needs of pharmaceutical manufacturers and distributors worldwide. Sun Rose International is recognized for its expertise in regulatory documentation and quality assurance, ensuring that its products meet international standards such as GMP. The company operates primarily as a merchant exporter, leveraging India's robust manufacturing base to supply essential medicines to markets in Asia, Africa, and Latin America.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Sun Rose International.